Drug Target Review – Issue 3 2019

Posted: 10 September 2019 | | No comments yet

This issue includes an investigation into utilising recombinant antibodies for research, a highlight on protein design using computational methods and an examination of the advances in genomic medicine. Also in the issue are articles on next generation sequencing and upstream bioprocessing. 

Included in this issue:

    Evaluation of therapeutic antibody discovery technologies
    Nancy Lopez-Anton, Antibody Discovery Group, Oxford Genetics
    Training and development in flow cytometry and other core technologies
    Derek Davies, The Francis Crick Institute
    The elegant parallel of using CRISPR to understand disease mechanisms
    Dr Mark Behlke, Integrated DNA Technologies (IDT)
    Spotlighting data in upstream bioprocesses – a recipe for quick and successful cell lines
    Unjulie Bhanot, IDBS
    Slowing progression in Parkinson’s
    Dr Heather Mortiboys, University of Sheffield’s Institute for Translational Neuroscience (SITraN)

The rest of this content is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here